Related Experiment Video
Updated: Jul 9, 2026
09:54
Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
Published on: February 16, 2020
QuantiFERON TB Gold: a new method for latent tuberculosis infection
Alessandra Bua1, Paola Molicotti, Giovanni Delogu
1Department of Biomedical Sciences, University of Sassari, Italy. ale.b76@email.it
The New Microbiologica
|December 18, 2007
Summary
QuantiFERON-TB Gold, approved for latent tuberculosis diagnosis, effectively identifies contact with Mycobacterium tuberculosis. This immunological tool aids in controlling tuberculosis when used with traditional methods.
Area of Science:
- Immunology
- Infectious Diseases
- Medical Diagnostics
Background:
- Latent tuberculosis diagnosis remains a challenge.
- The Food and Drug Administration approved QuantiFERON-TB Gold in 2003.
- There is a need for effective tools to identify Mycobacterium tuberculosis infections.
Purpose of the Study:
- To evaluate the QuantiFERON-TB Gold assay for immunological diagnosis of Mycobacterium tuberculosis infections.
- To assess its utility in diverse subject groups.
- To determine its role in tuberculosis control strategies.
Main Methods:
- Evaluation of QuantiFERON-TB Gold performance.
- Assessment across different subject cohorts.
- Comparison with traditional diagnostic techniques.
Main Results:
- QuantiFERON-TB Gold demonstrated specificity in identifying individuals exposed to M. tuberculosis.
- The assay showed potential for immunological diagnosis.
- Data supports its use in conjunction with existing methods.
Conclusions:
- QuantiFERON-TB Gold is a specific tool for detecting contact with M. tuberculosis.
- Its integration with traditional diagnostics can enhance tuberculosis control.
- The assay is a valuable instrument for managing tuberculosis infections.
Related Concept Videos
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...